Effect of Genetic Modifications on Pig Heart and Kidney Graft Survival in Baboons

$519,880U19FY2011AINIH

University Of Pittsburgh At Pittsburgh, Pittsburgh PA

Investigators

Linked publications & trials

Paper 39097214 Paper 38464515 Paper 38371908 Paper 38359908 Paper 38197953 Paper 38158188 Paper 37870485 Paper 37767640 Paper 37633449 Paper 37548030 Paper 37474379 Paper 37393920 Paper 37272417 Paper 37265370 Paper 37029499 Paper 36943143 Paper 36895262 Paper 36855794 Paper 36820525 Paper 36775767 Paper 36763972 Paper 36706064 Paper 36695679 Paper 36584382 Paper 36546291 Paper 36536507 Paper 36461918 Paper 36435961 Paper 36335558 Paper 36300760 Paper 36250568 Paper 36184321 Paper 36156826 Paper 36125388 Paper 36125166 Paper 36069244 Paper 35942912 Paper 35851182 Paper 35817653 Paper 35789146 Paper 35787933 Paper 35764060 Paper 35731912 Paper 35659792 Paper 35659123 Paper 35475475 Paper 35432379 Paper 35418974 Paper 35401039 Paper 35357044 Paper 35323162 Paper 35297098 Paper 35233893 Paper 35166407 Paper 35165943 Paper 35114360 Paper 35112383 Paper 35049144 Paper 35001436 Paper 34967057 Paper 34956220 Paper 34850468 Paper 34800323 Paper 34657336 Paper 34644438 Paper 34579956 Paper 34553390 Paper 34517284 Paper 34424601 Paper 34177906 Paper 34099346 Paper 34053125 Paper 34036638 Paper 34015463 Paper 33929061 Paper 33880816 Paper 33786912 Paper 33682188 Paper 33569837 Paper 33547674 Paper 33481554 Paper 33135299 Paper 33131148 Paper 33058285 Paper 33017208 Paper 32987208 Paper 32845539 Paper 32678137 Paper 32645781 Paper 32596827 Paper 32585053 Paper 32555507 Paper 32529670 Paper 32374061 Paper 32347584 Paper 31792154 Paper 31733178 Paper 31659811 Paper 31589847 Paper 31385888

Abstract

The proposed studies are directed towards resolving two inter-related current problems in pig-tononhuman primate (NHP) organ xenotransplantation using GTKO.CD46.CD55 pigs (designated GE pigs) (i) to identify a clinically-applicable regimen that prevents an adaptive immune response, and (ii) to identify a means of preventing coagulation dysfunction - in the form of thrombocytopenia and/or consumptive coagulopathy (CC) with associated thrombotic microangiopathy. The immune response may influence the development of coagulation disorders, and coagulation dysregulation may influence the immune response. The exact causative factors of CC remain uncertain, but (i) heightened innate immunity (antibody, complement, platelets, macrophages, NK cells), (ii) the adaptive immune response (T and B cells), and (iii) molecular incompatibilities between pig and NHP, may all play roles. Graft vascular heterogeneity may also be evident as CC and thrombocytopenia occur more rapidly in NHPs with pig kidney rather than heart grafts. We propose that genetic modifications in pigs and novel therapies may protect against these factors. We shall use CIITA mutant pigs (with knock-down of SLA Class II) and other pigs transgenic for human thromboregulatory factors on the GTKO background. Aim 1: To investigate the efficacy in baboons of a clinically-applicable immunosuppressive regimen in preventing the innate and adaptive immune responses after heterotopic heart Tx from (A) GE pigs (n=6) and (B) GE.CIITA pigs (n=6), and to determine whether prevention of elicited xenogeneic immunity correlates with delay in" the onset or prevention of coagulation dysfunction. Aim 2: To investigate the coagulation disorders that develop after (A) heterotopic heart Tx (n=6) or (B) lifesupporting kidney Tx (n=6) from GE.CIITA pigs additionally transgenic for human TBM in baboons immunosuppressed with a clinically-applicable regimen, and to determine the causes of graft failure and coagulation dysfunction. Aim 3: To investigate the coagulation disorders that develop after (A) heterotopic heart Tx (n=6) or (B) lifesupporting kidney Tx (n=6) from GE.CIITA.TBM pigs additionally transgenic for human EPCR in baboons immunosuppressed with a clinically-applicable regimen, and to determine the causes of graft failure and coagulation dysfunction.

View original record on NIH RePORTER →